HCA Healthcare (HCA) Q3 2026 earnings review
HCA Healthcare patient visits rise, but uninsured care hurts profit
HCA Healthcare, the largest US hospital operator, treated more patients and held down labor costs even as surging uninsured visits weighed on profit. Revenue rose 4% to $19.8 billion, and same-facility equivalent admissions grew 3%. Because patients who lost health insurance exchange coverage cost the company $400 million in pre-tax profit, net income fell, though share buybacks lifted profit per share. Chief executive Sam Hazen said the group now expects full-year results in the upper half of its prior outlook.
| Revenue | $19.85B +3.6% from a year ago |
|---|---|
| Profit per share, excluding one-offs | $7.22 +3.7% from a year ago |
| Exchange coverage pre-tax hit | ~$400M brings nine-month hit to ~$950M |
| Full-year outlook | Upper half of prior $15.4B–$16.1B Adjusted EBITDA range |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because stronger hospital admissions and lower labor costs balanced out a worse-than-planned hit from uninsured patients. Moving to the upper half of the full-year plan lifts implied fourth-quarter operating profit growth back into positive territory, by our math. One caution: the $400 million third-quarter hit from insurance exchanges ran above the $225 million to $325 million quarterly pace implied by the company's own full-year plan.
The question now is whether the wave of uninsured patients has peaked or will keep squeezing hospital margins in 2027. Either tighter cost controls and easier comparisons let operating profit rebound, or ongoing surgery declines and coverage losses hold growth down. Fourth-quarter exchange losses and the initial 2027 outlook on the next call will settle it.
🐂 Bull Case
Patient Admissions Sped Up and Labor Costs Fell
HCA Healthcare runs 189 hospitals and about 2,600 outpatient clinics across the United States and the United Kingdom. Even as more patients arrived without insurance, the hospital operator treated more people and kept a tight lid on staff and supply bills.
The company said "growth accelerated in same facility equivalent admissions and insured revenue per equivalent admission (excluding Medicaid Supplemental Payment Programs); cost results improved". Equivalent admissions, which combine overnight hospital stays and outpatient visits into a single volume measure, rose 3.0% at hospitals open at least a year, while emergency room visits jumped 5.1%.
Higher patient volume helped the group control unit labor costs. Salaries and benefits fell 0.4 percentage points of revenue to 43.2%, and supplies dropped 0.3 percentage points to 14.2%. By our math, reported pay and benefits per equivalent admission edged down 0.2% from a year ago, showing that hospital staffing remains steady.
What to watch: same-facility pay and benefits per equivalent admission in the third-quarter filing. A reading near zero or below would confirm that labor discipline is offsetting half of the insurance coverage drag.
HCA Pointed to the Upper Half of Its Plan
"Despite the challenges brought about by federal policy changes this year, our colleagues have continued to provide high-quality care to patients, and we believe HCA Healthcare is positioned to end the year positively," chief executive Sam Hazen said. To back that up, the hospital group said full-year operating results will land "in the upper half of its 2026 estimated guidance ranges previously issued on July 14, 2026".
The company did not print a new forecast table, but pointing to the upper half raises the effective target after last quarter's cut. By our math, the middle of the printed table would have left fourth-quarter Adjusted EBITDA — earnings before interest, taxes, depreciation and amortization, excluding one-offs — down 2.7% from a year ago. Moving to the middle of the upper half lifts implied fourth-quarter Adjusted EBITDA growth to 1.6%, ahead of the third quarter's 1.2% pace.
What to watch: fourth-quarter Adjusted EBITDA growth against the third quarter's 1.2% rate. A higher growth rate in the fourth quarter would show that the insurance exchange shock is easing as the year ends.
Share Buybacks Lifted Per-Share Profit as Debt Rose
HCA uses heavy share buybacks to grow per-share profit when hospital earnings slow, though critics note that borrowing to buy shares adds balance-sheet risk. In the third quarter, net income attributable to the company fell 3.9% to $1.579 billion, or 4.6% excluding facility sales.
Yet diluted earnings per share rose 4.5% to $7.27, and 3.7% excluding one-offs to $7.22. The US company spent $2.97 billion to buy back 7.23 million shares during the quarter, cutting its diluted share count by 8.0% from a year ago. Because the group also spent $1.357 billion on capital projects, total debt climbed to $50.493 billion, with $8.093 billion due within one year and credit facility availability down to $2.226 billion.
What to watch: short-term borrowings and credit facility availability at year-end. If debt due within one year keeps climbing while credit availability shrinks, HCA will have to slow its buybacks in 2027.
🐻 Bear Case
Exchange Coverage Losses Cost Another $400 Million
Federal subsidies known as enhanced premium tax credits expired at the end of 2025, causing patients to drop their government-subsidized health plans. Three months ago, HCA estimated this shift would hurt full-year pre-tax profit by $1.0 billion to $1.2 billion, after roughly $550 million of damage across the first two quarters.
In the third quarter, the company again saw higher uninsured volume "primarily due to patients who lost coverage on the health insurance exchanges". Management estimated this shift reduced pre-tax income by about $400 million in the quarter. Last quarter's $400 million hit included a $75 million catch-up from the first quarter, so the single-quarter damage actually grew.
This cuts against the idea that the insurance shock is stabilizing. By our math, after $550 million in the first half, the full-year plan left $450 million to $650 million for the entire second half, or $225 million to $325 million per quarter. Burning $400 million in the third quarter alone means full-year losses will top $1.2 billion unless fourth-quarter uninsured visits drop sharply.
What to watch: the fourth-quarter pre-tax impact from health insurance exchanges and the 2027 outlook on the next call. Another hit near $400 million would prove the coverage loss is still growing into 2027.
Uninsured Patients Keep Squeezing Pricing and Margins
Over the past year, state Medicaid supplemental payment programs — extra state funds paid to hospitals that treat low-income patients — drove HCA's revenue per patient higher, including a 21-month catch-up payment in Florida last quarter. Without a similar windfall in the third quarter, the rise in uninsured patients weighed directly on hospital pricing and margins.
- Same-facility revenue per equivalent admission: up 0.6% from a year ago, down from 6.4% growth in the second quarter
- Other operating expenses: 23.0% of revenue, up 1.2 percentage points from 21.8% a year ago
- Adjusted EBITDA margin: 19.7%, down 0.5 percentage points from 20.2% a year ago
The company noted that the net benefit from Medicaid supplemental programs "modestly increased" from a year ago, and that revenue per insured patient grew faster when excluding those programs. Even so, treating more uninsured patients meant HCA collected almost nothing on a larger share of its care, while state program fees kept other operating expenses high.
What to watch: same-facility revenue per equivalent admission in the fourth quarter. Another reading below 1% would show that routine price increases on insured patients cannot offset the uninsured wave without lump-sum state payments.
Outpatient and Inpatient Surgeries Kept Falling
Surgical procedures are among the most profitable treatments a hospital performs, so falling surgery counts hurt revenue mix even when emergency rooms are busy. HCA operated 117 freestanding outpatient surgery centers at the end of September, down from 123 a year earlier.
In the third quarter, same-facility outpatient surgeries fell 3.7% from a year ago, worse than the 3.4% drop in the second quarter. Same-facility inpatient surgeries declined 1.4%, marking the third straight quarter of falling surgical volumes across both settings. Emergency room visits and general medical admissions carried all of the company's volume growth, which leaves facilities with a less profitable mix of care.
What to watch: same-facility outpatient surgery growth in the fourth quarter. A fourth straight drop would show that patients are putting off elective procedures beyond the initial insurance exchange disruption.
Risks this quarter didn't answer
Six standing concerns from prior quarters could not be read from the third-quarter earnings release because the details live in the quarterly filing or the conference call.
- Insurance exchange volume drop: not in the release; the call and filing will show if exchange admissions held at the 15% decline rate seen in the first half.
- Cost-saving program dollars: management cited "anticipated results from resiliency initiatives", but gave no dollar savings against its $400 million full-year target.
- Doctor fee inflation: subsidies for hospital-based specialists like anesthesiologists and radiologists live in the filing's expense breakdown.
- Uncompensated care and Medicaid approvals: the exact charity care bill and Texas Medicaid conversion rates wait for the quarterly filing.
- Insurer claim denials: disputes with Medicare Advantage plans are only discussed on the call.
- 2027 Medicaid work rules: any estimate of next year's state coverage rules waits for 2027 outlook commentary.
💲 Other KPIs
Cash from operations rose 1.0% from a year ago to $4.461 billion, rebounding from a 44.5% drop in the second quarter. Accounts receivable — bills owed by insurers and patients — fell $772 million from June to $11.509 billion as HCA collected delayed state payments, though nine-month operating cash flow of $8.810 billion still trails last year's $10.277 billion.
Spending on hospital buildings and equipment, excluding acquisitions, rose 5.4% from a year ago to $1.357 billion, or 6.8% of revenue. Through nine months, capital spending reached $3.707 billion, up from $3.455 billion last year, keeping the group on track for its $5.0 billion to $5.5 billion full-year building plan.
🔮 Guidance
Raised. HCA kept the printed table unchanged but said results will land in the upper half ($78.25 billion to $79.50 billion), lifting the middle of the target range to about 4.3% growth. By our math, that upper-half midpoint leaves fourth-quarter revenue up 0.9% from a year ago, down from 3.6% in the third quarter.
Raised. Pointing to the upper half ($15.75 billion to $16.10 billion) reverses most of last quarter's cut, putting the effective midpoint at $15.925 billion, or 2.3% growth. By our math, that leaves fourth-quarter Adjusted EBITDA up 1.6% from a year ago, versus a 2.7% drop at the full table's midpoint.
Raised. The hospital group now expects net income in the upper half ($6.50 billion to $6.70 billion), which still means full-year profit falls about 2.7% at the $6.60 billion upper-half midpoint. By our math, after $4.898 billion in the first nine months, that leaves fourth-quarter net income down about 9.4% against a strong prior-year quarter.
Raised. Guiding to the upper half ($29.60 to $30.50) lifts the effective midpoint by $0.45 to $30.05, or 6.5% growth over last year's $28.21 per share excluding one-offs. By our math, that leaves fourth-quarter diluted earnings per share at $8.00, down 1.7% from $8.14 a year ago, assuming 219.5 million full-year shares.
Unchanged. The forecast table keeps full-year depreciation and amortization at $3.77 billion in the middle of the range, up 7.0% from last year. After $2.828 billion in the first nine months, that leaves $942 million for the fourth quarter.
Unchanged. Full-year interest expense stays at $2.44 billion in the middle of the range, up 8.5% from 2025 as total debt passed $50 billion. After $1.790 billion in the first nine months, that leaves $650 million for the fourth quarter.
Unchanged. The full-year tax provision remains at $2.05 billion at the middle of the range. After $1.515 billion in the first nine months, that leaves $535 million for the fourth quarter.
Unchanged. Profit belonging to joint-venture partners stays at $990 million at the middle of the range. After $738 million through nine months, that leaves $252 million for the fourth quarter.
❓ Key Questions
Will full-year exchange losses exceed the $1.2 billion cap?
Uninsured shifts from the health insurance exchanges cost $400 million in the third quarter, bringing the nine-month total to about $950 million. That leaves only $250 million of room under the $1.2 billion worst-case full-year estimate.
Did health insurance exchange admissions drop more than 15%?
In both the first and second quarters, equivalent admissions from the health insurance exchanges fell 15% from a year ago. The third-quarter release did not give this figure, which shows whether coverage losses have stopped worsening.
How many dollars has the cost resiliency program saved?
HCA said cost results improved and pointed to its resiliency initiatives in the outlook, but has not reported how much of its $400 million 2026 savings target it has actually achieved.
Why are outpatient surgeries falling faster while ER visits grow?
Same-facility outpatient surgeries fell 3.7% in the third quarter even as emergency room visits rose 5.1%. Investors need to know how much of the surgery drop comes from uninsured patients putting off care versus competition from rival clinics.